The global Aptamers market is projected to reach $ 1,724.5 million by 2030, growing at a CAGR of 18.1%
Aptamer is used as antibodies for many applications and is a versatile cost effective product. Aptamers have many advantages compared to protein therapeutics with respect to size, accessibility and modification by chemistry. Aptamers is highly effective and has very low manufacturing costs and is used in treatment of diseases like AIDS, HIV in the low economy countries. Aptamers Market size is growing due to its extensive use as pharmaceutical leads, detection reagent and proteomic levels and small molecules. Aptamer can be made to have extremely high affinity and presence of huge targets.
Furthermore, there is lots of research and development in the sector of biotechnology and pharmaceutical industries which is influencing the growth of Aptamers Market size. Apart from this the growing investment in the sector is also a factor driving the market growth. The various advantages offered by Aptamers as compared to other elements is the reason for which has led to growth.
There are various regulations and rules associated with use of Aptamers, and some of these are not fulfilled by many of the Aptamers which causes organizations to close their research process in the mid-way. This is one factor that might hamper the growth of Aptamers Market share. Furthermore, there is extremely low or negligible awareness among public about the various benefits of Aptamers. Especially so in the developing and low income countries.
Aptamers Market size is segmented based on type, application, technology, end user and region. Segmentation on the basis of type is done as DNA, RNA and XNA based Aptamers. Among these the DNA-based Aptamers contributes maximum share to the Aptamers market share. This is closely followed by XNA-based Aptamers that will grow at a high CAGR during the forecast period. Segmentation on the basis of application is done as diagnostic, research and development, therapeutics development and many others. Out of these the diagnostic sector contributes the maximum to the market share.
Segmentation of the Aptamers Market size on the basis of technologies is done as SELEX and others. SELEX contributes to the maximum market share whereas the other technologies are in a growth stage, owing to the research and development in the sector. Segmentation on the basis of end user is done as Contract research organizations (CROs), academic and government research institutes, biotechnology and pharmaceutical companies and many others. The academic and government research institutes contributes the maximum to the Aptamers Market Share. Similarly, the biotechnology and pharmaceutical companies would be leading and growing segment during the forecast period. Aptamers Market trend study indicates market segmentation as Europe, Americas, Asia and ROW (Rest of World). Americas is leading in Aptamers market share and is set to grow over the years.
Key players of the Global Aptamers Market are Aptus Biotech S.L., TriLink BioTechnologies, NeoVentures Biotechnology, Aptagen and many more.
Aptamers Market Scope
|Forecast Unit||Value (USD)|
|Revenue forecast in 2030||$ 1,724.5 million|
|Growth Rate||CAGR of 18.1% during 2021-2030|
|Segment Covered||by Type, Technology, Regions|
|Regions Covered||North America, Europe, Asia Pacific, South America, Middle East and Africa|
|Key Players Profiled||SomaLogic; Aptamer Group; Aptamer Sciences, Inc.; Base Pair Biotechnologies; Noxxon Pharma; Vivonics, Inc.; Aptagen, LLC; TriLink Biotechnologies|
The various segments of Global Aptamers Market are:
- DNA Based Aptamers
- RNA Based Aptamers
- XNA based Aptamers
- Research and Development
- Therapeutics Development
- Contract research organizations (CROs)
- Academic and government research institutes
- ROW (Rest of World)